Results for skinny label
AIPPI Rapid Response Report: Debating Lyrica's recurring pain on plausibility, abuse and infringement AIPPI Rapid Response Report:  Debating Lyrica's recurring pain on plausibility, abuse and infringement Reviewed by David Brophy on Thursday, December 08, 2016 Rating: 5
Young EPLAW Congress: Brexit, SPCs, Skinny Labels and SEPs washed down with ample amounts of Belgian beer Young EPLAW Congress: Brexit, SPCs, Skinny Labels and SEPs washed down with ample amounts of Belgian beer Reviewed by Annsley Merelle Ward on Tuesday, April 19, 2016 Rating: 5
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? Fordham 2016:  Will purposive construction of Swiss-type claims save second-medical use patents?  Reviewed by Annsley Merelle Ward on Tuesday, April 05, 2016 Rating: 5
Yet another pregabalin decision - application to amend struck out as abuse of process Yet another pregabalin decision - application to amend struck out as abuse of process Reviewed by Darren Smyth on Wednesday, November 25, 2015 Rating: 5
Vive la différence? No need for Pregabalin(e) injunction, say the French Vive la différence? No need for Pregabalin(e) injunction, say the French Reviewed by Jeremy on Wednesday, November 11, 2015 Rating: 5
When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued Reviewed by Jeremy on Monday, November 09, 2015 Rating: 5
The Lyrica patent dispute – part the second - infringement The Lyrica patent dispute – part the second - infringement Reviewed by Darren Smyth on Friday, November 06, 2015 Rating: 5
Powered by Blogger.